Search - tctmd.com

Displaying 461 - 480 of 1847

Sort: Relevancy | Date

Presentation THT 2024

Stabilzers, Silencers. and Amyloid Extractor: OH MY! It Is a Rapidly Evolving Landscape

Presenter: Matthew S. Maurer

March 05, 2024

Presentation THT 2024

Multimodal Imaging Is Needed for Early Diagnosis and Monitoring of Therapy

Presenter: Sharmila Dorbala

March 05, 2024

Presentation THT 2024

How Can We Find Cardiac Amyloidosis Not Amyloid Early?

Presenter: Frederick L. Ruberg

March 05, 2024

Presentation THT 2024

Amyloidosis Is Everywhere: Is It Really a Rare Disease?

Presenter: Mazen Hanna

March 05, 2024

Presentation THT Abstracts 2024

In-Hospital Mortality Rate and Predictors of 30-Day Readmission in Patients with Heart Failure and HIV disease-A Cross Sectional Study from Nationwide Readmission Database

Presenter: Badri Aryal

March 04, 2024

Presentation THT 2024

Overlap Between Valvular Heart Diseases and HFpEF

Presenter: Yogesh Reddy

March 04, 2024

Presentation Miami Valves 2024

Mitral Valve Disease: PMV for MAC MS

Presenter: Igor F. Palacios

February 03, 2024

Presentation Miami Valves 2024

TAVR in Bicuspid Aortic Valve Disease Where Are We Now?

Presenter: Nicolas M. Van Mieghem

February 03, 2024

Presentation Miami Valves 2024

TAVR in Bicuspid Aortic Valve Disease Where Are We Now?

Presenter: Nicolas M. Van Mieghem

February 03, 2024

Presentation Miami Valves 2024

Structural Heart Disease and Treatment

Presenter: Vivian Avila

February 03, 2024

Presentation Miami Valves 2024

Full Court Press: Is it Really Necessary in Valve Disease?

Presenter: Elliott Elias

February 01, 2024

Presentation Miami Valves 2024

Catheter Based Treatment of Structural Heart Disease: Year in Review

Presenter: Eduardo de Marchena

February 01, 2024

Presentation TCT 2023

Interventional Procedures in High-Risk Decompensated Valvular Heart Disease

Presenter: Thomas Waggoner

October 26, 2023

Presentation TCT 2023

TCT 720: Patient-Reported Outcomes in Tricuspid Valve Intervention: Patient Preference Results from the TRISCEND II Trial

Presenter: Colin Barker

October 26, 2023

TCT 768: Early echocardiographic and hemodynamic changes after caval aortic valve implantation for severe tricuspid regurgitation

Presentation TCT 2023

TCT 768: Early Echocardiographic and Hemodynamic Changes After Caval Valve Implantation

Presenter: Ottavia Cozzi

October 26, 2023

Presentation TCT 2023

TCT 513: Real-world Clinical Outcomes and Health Care Utilization in Patients with Severe Tricuspid Regurgitation

Presenter: Mahesh Madhavan

October 26, 2023

Presentation TCT 2023

TCT 500: Computed Tomography Anatomic Predictors of Procedural Success in Patients Undergoing Tricuspid Transcatheter Edge-to-Edge Repair.

Presenter: Joanna Bartkowiak

October 26, 2023

Presentation TCT 2023

TCT 689: 30-Day Readmissions of Percutaneous Mechanical Aspiration of Tricuspid Valve Vegetation

Presenter: Cody Morgan Boyer-Sprouse

October 26, 2023

Presentation TCT 2023

TCT 665: A Real-World Comparative Analysis of Surgical and Transcatheter Approaches to Tricuspid Regurgitation

Presenter: Federica Gramegna

October 26, 2023

Presentation TCT 2023

TCT 340: Sex Differences in Patients with Three-vessel Coronary Artery Disease Undergoing FFR-guided PCI or CABG: A Pre-specified Analysis of the FAME 3 Trial

Presenter: Kuniaki Takahashi

October 26, 2023

Advertisement

Stabilzers, Silencers. and Amyloid Extractor: OH MY! It Is a Rapidly Evolving Landscape

Multimodal Imaging Is Needed for Early Diagnosis and Monitoring of Therapy

How Can We Find Cardiac Amyloidosis Not Amyloid Early?

Amyloidosis Is Everywhere: Is It Really a Rare Disease?

In-Hospital Mortality Rate and Predictors of 30-Day Readmission in Patients with Heart Failure and HIV disease-A Cross Sectional Study from Nationwide Readmission Database

Overlap Between Valvular Heart Diseases and HFpEF

Mitral Valve Disease: PMV for MAC MS

TAVR in Bicuspid Aortic Valve Disease Where Are We Now?

TAVR in Bicuspid Aortic Valve Disease Where Are We Now?

Structural Heart Disease and Treatment

Full Court Press: Is it Really Necessary in Valve Disease?

Catheter Based Treatment of Structural Heart Disease: Year in Review

Interventional Procedures in High-Risk Decompensated Valvular Heart Disease

TCT 720: Patient-Reported Outcomes in Tricuspid Valve Intervention: Patient Preference Results from the TRISCEND II Trial

TCT 768: Early Echocardiographic and Hemodynamic Changes After Caval Valve Implantation

TCT 513: Real-world Clinical Outcomes and Health Care Utilization in Patients with Severe Tricuspid Regurgitation

TCT 500: Computed Tomography Anatomic Predictors of Procedural Success in Patients Undergoing Tricuspid Transcatheter Edge-to-Edge Repair.

TCT 689: 30-Day Readmissions of Percutaneous Mechanical Aspiration of Tricuspid Valve Vegetation

TCT 665: A Real-World Comparative Analysis of Surgical and Transcatheter Approaches to Tricuspid Regurgitation

TCT 340: Sex Differences in Patients with Three-vessel Coronary Artery Disease Undergoing FFR-guided PCI or CABG: A Pre-specified Analysis of the FAME 3 Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content